This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012; 25: 264–96.Robert-GangneuxFDardéMLEpidemiology of and diagnostic strategies for toxoplasmosisClin Microbiol Rev2012252649610.1128/CMR.05013-11Search in Google Scholar
Kasper LH. Toxoplasma infections. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, et al., editors. Harrison’s principles of internal medicine. 17th Edition. New York: McGraw Hill Medical; 2008. p. 1305–11.KasperLHToxoplasma infectionsFauciASKasperDLLongoDLBraunwaldEHauserSLJamesonJLeditorsHarrison’s principles of internal medicine.17th EditionNew YorkMcGraw Hill Medical2008130511Search in Google Scholar
Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 12; 363(9425): 1965–76.MontoyaJGLiesenfeldOToxoplasmosisLancet200412363942519657610.1016/S0140-6736(04)16412-XSearch in Google Scholar
Schmidt-Hieber M, Zweigner J, Uharek L, Blau IW, Thiel E. Central nervous system infections in immunocompromised patients: update on diagnostics and therapy. Leuk Lymphoma 2009; 50: 24–36.Schmidt-HieberMZweignerJUharekLBlauIWThielECentral nervous system infections in immunocompromised patients: update on diagnostics and therapyLeuk Lymphoma200950243610.1080/1042819080251774019031169Search in Google Scholar
Yan J, Huang B, Liu G, Wu B, Huang S, Zheng H, et al. Meta-analysis of prevention and treatment of toxoplasmic encephalitis in HIV-infected patients. Acta Trop 2013; 127: 236–44.YanJHuangBLiuGWuBHuangSZhengHMeta-analysis of prevention and treatment of toxoplasmic encephalitis in HIV-infected patientsActa Trop20131272364410.1016/j.actatropica.2013.05.00623707647Search in Google Scholar
Mele A, Paterson P, Prentice H, Leoni P, Kibbler C. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant 2002; 29: 691–8.MeleAPatersonPPrenticeHLeoniPKibblerCToxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literatureBone Marrow Transplant200229691810.1038/sj.bmt.170342512180115Search in Google Scholar
Da Cunha S, Ferreira E, Ramos I, Martins R. Cerebral toxoplasmosis after renal transplantation. Case report and review. Acta Medica Port 1994; 7: 61–6.Da CunhaSFerreiraERamosIMartinsRCerebral toxoplasmosis after renal transplantation. Case report and reviewActa Medica Port19947616Search in Google Scholar
Abdel Razek AA, Watcharakorn A, Castillo M. Parasitic diseases of the central nervous system. Neuroimaging Clin N Am 2011; 21: 815–41.Abdel RazekAAWatcharakornACastilloMParasitic diseases of the central nervous systemNeuroimaging Clin N Am2011218154110.1016/j.nic.2011.07.00522032501Search in Google Scholar
Offiah CE, Turnbull IW. The imaging appearances of intracranial CNS infections in adult HIV and AIDS patients. Clin Radiol 2006; 61: 393–401.OffiahCETurnbullIWThe imaging appearances of intracranial CNS infections in adult HIV and AIDS patientsClin Radiol20066139340110.1016/j.crad.2006.01.00816679111Search in Google Scholar
Masamed R, Meleis A, Lee EW, Hathout GM. Cerebral toxoplasmosis: case review and description of a new imaging sign. Clin Radiol 2009; 64: 560–3.MasamedRMeleisALeeEWHathoutGMCerebral toxoplasmosis: case review and description of a new imaging signClin Radiol200964560310.1016/j.crad.2008.09.01619348854Search in Google Scholar
Ionita C, Wasay M, Balos L, Bakshi R. MR imaging in toxoplasmosis encephalitis after bone marrow transplantation: paucity of enhancement despite fulminant disease. Am J Neuroradiol 2004; 25: 270–3.IonitaCWasayMBalosLBakshiRMR imaging in toxoplasmosis encephalitis after bone marrow transplantation: paucity of enhancement despite fulminant diseaseAm J Neuroradiol2004252703Search in Google Scholar
Miller RF, Hall-Craggs MA, Costa DC, Brink NS, Scaravilli F, Lucas SB, et al. Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS. Sex Transm Infect 1998; 74: 258–64.MillerRFHall-CraggsMACostaDCBrinkNSScaravilliFLucasSBMagnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDSSex Transm Infect1998742586410.1136/sti.74.4.25817581329924465Search in Google Scholar
Camacho DL a, Smith JK, Castillo M. Differentiation of toxoplasmosis and lymphoma in AIDS patients by using apparent diffusion coefficients. Am J Neuroradiol 2003; 24: 633–7.Camacho DLaSmithJKCastilloMDifferentiation of toxoplasmosis and lymphoma in AIDS patients by using apparent diffusion coefficientsAm J Neuroradiol2003246337Search in Google Scholar
Sarrazin JL, Bonneville F, Martin-Blondel G. Brain infections. Diagn Interv Imaging 2012; 93: 473–90.SarrazinJLBonnevilleFMartin-Blondel G. Brain infectionsDiagn Interv Imaging2012934739010.1016/j.diii.2012.04.02022677301Search in Google Scholar
Maza S, Buchert R, Brenner W, Munz DL, Thiel E, Korfel A, et al. Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma. Radiol Oncol 2013; 47: 103–110.MazaSBuchertRBrennerWMunzDLThielEKorfelABrain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphomaRadiol Oncol20134710311010.2478/raon-2013-0016369108423801905Search in Google Scholar
Abedalthagafi M, Rushing EJ, Garvin D, Cheson B, Ozdemirli M. Asymptomatic diffuse “encephalitic” cerebral toxoplasmosis in a patient with chronic lymphocytic leukemia: case report and review of the literature. Int J Clin Exp Pathol 2009; 3: 106–9.AbedalthagafiMRushingEJGarvinDChesonBOzdemirliMAsymptomatic diffuse “encephalitic” cerebral toxoplasmosis in a patient with chronic lymphocytic leukemia: case report and review of the literatureInt J Clin Exp Pathol200931069Search in Google Scholar
Touahri T, Pulik M, Fezoui H, Genet P, Lionnet F, Louvel D. Toxoplasmic encephalitis in a non-HIV patient with follicular lymphoma. Int J Hematol 2002; 75: 111–2.TouahriTPulikMFezouiHGenetPLionnetFLouvelDToxoplasmic encephalitis in a non-HIV patient with follicular lymphomaInt J Hematol200275111210.1007/BF0298199211843284Search in Google Scholar
Marcus R, Hagenbeek A. The therapeutic use of rituximab in non-Hodgkin’s lymphoma. Eur J Haematol Suppl 2007; 67: 5–14.MarcusRHagenbeekAThe therapeutic use of rituximab in non-Hodgkin’s lymphomaEur J Haematol Suppl20076751410.1111/j.1600-0609.2006.00789.x17206982Search in Google Scholar
Lanini S, Molloy AC, Prentice AG, Ippolito G, Kibbler CC. Infections in patients taking rituximab for hematologic malignancies: two-year cohort study. BMC Infect Dis 2013; 13: 317.LaniniSMolloyACPrenticeAGIppolitoGKibblerCCInfections in patients taking rituximab for hematologic malignancies: two-year cohort studyBMC Infect Dis20131331710.1186/1471-2334-13-317371662423849292Search in Google Scholar
Eisenberg R. Update on rituximab. Ann Rheum Dis 2005; 64(Suppl 4): iv55-7.EisenbergRUpdate on rituximabAnn Rheum Dis200564Suppl 4iv55710.1136/ard.2005.042648176690416239389Search in Google Scholar
Gürcan HM, Keskin DB, Stern JNH, Nitzberg MA, Shekhani H, Ahmed AR. A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol 2009; 9: 10–25.GürcanHMKeskinDBSternJNHNitzbergMAShekhaniHAhmedARA review of the current use of rituximab in autoimmune diseasesInt Immunopharmacol20099102510.1016/j.intimp.2008.10.00419000786Search in Google Scholar
Kelesidis T, Daikos G, Boumpas D, Tsiodras S. Does rituximab increase the incidence of infectious complications? A narrative review. Int J Infect Dis 2011; 15: e2–16.KelesidisTDaikosGBoumpasDTsiodrasSDoes rituximab increase the incidence of infectious complications? A narrative reviewInt J Infect Dis201115e21610.1016/j.ijid.2010.03.025805344421074471Search in Google Scholar
Amezcua Vesely MC, Bermejo DA, Montes CL, Acosta-Rodríguez EV, Gruppi A. B-Cell response during protozoan parasite infections. J Parasitol Res 2012; 2012: 362131.Amezcua VeselyMCBermejoDAMontesCLAcosta-RodríguezEVGruppiAB-Cell response during protozoan parasite infectionsJ Parasitol Res2012201236213110.1155/2012/362131327043522315659Search in Google Scholar
Safa G, Darrieux L. Cerebral toxoplasmosis after rituximab therapy. JAMA Intern Med 2013; 173: 924–6.SafaGDarrieuxLCerebral toxoplasmosis after rituximab therapyJAMA Intern Med2013173924610.1001/jamainternmed.2013.37423589123Search in Google Scholar
Derouin F, Pelloux H. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 2008; 14: 1089–101.DerouinFPellouxHPrevention of toxoplasmosis in transplant patientsClin Microbiol Infect200814108910110.1111/j.1469-0691.2008.02091.x19018809Search in Google Scholar
Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58(RR-4): 1–207.KaplanJEBensonCHolmesKKBrooksJTPauAMasurHGuidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of AmericaMMWR Recomm Rep200958RR-4120710.1037/e537722009-001Search in Google Scholar
Soave R. Prophylaxis strategies for solid-organ transplantation. Clin Infect Dis 2001; 33(Suppl 1): S26-31.SoaveRProphylaxis strategies for solid-organ transplantationClin Infect Dis200133Suppl 1S263110.1086/32090111389519Search in Google Scholar
